The call comes in as chest pain. Your 62-year-old male patient is diaphoretic, nauseated, and in moderate distress. His 12-lead shows ST elevation in leads II, III, and aVF — a classic inferior STEMI. You reach for the nitroglycerin. His blood pressure is 84/52 mmHg. You stop.
That pause — and the clinical reasoning that drives it — is the difference between a save and a code.
The Anatomy of a Deadly Reflex
Nitroglycerin is one of the most commonly administered prehospital medications. For anterior STEMI, unstable angina, and hypertensive emergencies with chest pain, it is safe and effective. It works by dilating venous capacitance vessels, reducing preload, and decreasing myocardial oxygen demand. In most chest pain presentations, this is exactly what you want.
In right ventricular infarction (RVI), it is exactly what you do not want.
The right ventricle is a thin-walled, low-pressure chamber that is exquisitely preload-dependent. When the right coronary artery (RCA) occludes in an inferior STEMI, the RV loses its contractile function. The only way it can maintain forward flow to the left ventricle — and therefore maintain cardiac output — is by relying on adequate venous return (preload). Nitroglycerin reduces preload. In a preload-dependent RV, this can precipitate catastrophic hypotension and cardiogenic shock.
Current ACC/AHA acute coronary syndromes guidance (2025) is unambiguous on this point: in right ventricular infarction, nitroglycerin, morphine, and diuretics are contraindicated because of their preload-reducing effects.
How Common Is Right Ventricular Involvement?
This is not a rare edge case. Right ventricular infarction complicates 30–50% of inferior STEMIs, making it one of the most common high-risk presentations in prehospital cardiac care. The RCA supplies both the inferior wall of the left ventricle and the right ventricle in the majority of patients (right-dominant circulation). When the proximal RCA occludes, both territories are at risk.
| Feature | Inferior STEMI Without RVI | Inferior STEMI With RVI |
|---|---|---|
| ST elevation leads | II, III, aVF | II, III, aVF + V4R |
| Blood pressure | Variable | Often hypotensive |
| JVD | Absent | Present (Kussmaul's sign) |
| Lung sounds | May be wet | Clear (no pulmonary edema) |
| Nitroglycerin | Use with caution if BP >90 | Contraindicated |
| Treatment | Standard STEMI protocol | IV fluid bolus, avoid preload reducers |
The Clinical Triad: How to Recognize RVI in the Field
The classic teaching triad for right ventricular infarction is hypotension, clear lung fields, and jugular venous distension (JVD) in the setting of an inferior STEMI. In practice, all three findings are not always present simultaneously, but any combination should raise your suspicion and prompt right-sided lead acquisition.
The most important diagnostic step you can take in the field is obtaining a right-sided 12-lead ECG — specifically lead V4R. ST elevation of ≥1 mm in V4R in the setting of an inferior STEMI is highly sensitive and specific for right ventricular involvement. This single finding changes your entire treatment approach.
Bedside Recognition Checklist
- ST elevation in II, III, aVF (inferior STEMI confirmed)
- Hypotension or borderline BP (systolic <100 mmHg)
- JVD without pulmonary edema (clear lung sounds)
- Bradycardia or heart block (RCA supplies AV node in most patients)
- ST elevation in V4R on right-sided leads
What Happens When You Give Nitroglycerin
When you administer nitroglycerin to a patient with RVI, the venodilation reduces venous return to an already-failing right ventricle. Cardiac output drops precipitously. The patient who was hypotensive at 84/52 mmHg can drop to 52/30 mmHg within minutes. This is not a gradual decline — it can be sudden and severe, requiring vasopressor support and aggressive resuscitation.
The same contraindication applies to morphine (which also causes venodilation and reduces preload) and to diuretics. All three drugs that are commonly reflexively administered in chest pain presentations are contraindicated in RVI for the same physiologic reason.
The Correct Prehospital Treatment
The treatment for inferior STEMI with RVI is the opposite of what you would do for left ventricular failure:
IV fluid bolus: 250–500 mL normal saline to augment preload and support right ventricular output. This is the cornerstone of prehospital RVI management. The right ventricle needs volume to push blood forward through the pulmonary circulation to the left ventricle.
Avoid all preload-reducing agents: Nitroglycerin, morphine, and diuretics are all contraindicated. If the patient is in pain, consider fentanyl — it has minimal hemodynamic effects at analgesic doses and does not significantly reduce preload.
Manage bradycardia and heart block: The RCA supplies the AV node in approximately 90% of patients. Inferior STEMI with RVI frequently produces high-degree AV block. Atropine is first-line for symptomatic bradycardia; transcutaneous pacing may be required for complete heart block.
Rapid transport and cath lab activation: Time to reperfusion is the definitive treatment. Activate the cath lab early and communicate the RVI finding to the receiving team so they are prepared for a hemodynamically complex patient.
The Simulation That Builds This Pattern Recognition
The clinical knowledge is straightforward once you have it. The challenge is that in the field, the reflex to give nitroglycerin for chest pain is deeply ingrained — and the window between recognition and administration can be seconds. Building the habit of checking for RVI before reaching for nitrates requires deliberate practice, not just reading.
The Nitroglycerin in RVI simulation on EMS-MedSim places you in exactly this scenario: a 62-year-old male, inferior STEMI, HR 52, BP 84/52, JVD, clear lungs. You must acquire right-sided leads, recognize V4R elevation, and choose fluid resuscitation over nitroglycerin. Students who administer nitro experience the consequence — BP drops to 52/30, vasopressor rescue required — in a safe environment where the lesson is permanent. Students who choose correctly learn the full pathway: fluids, AV block management, and cath lab handoff.
Key Takeaways
Nitroglycerin is a safe and effective drug in most chest pain presentations. It becomes dangerous in the specific context of inferior STEMI with right ventricular infarction, where preload reduction removes the only mechanism by which a failing RV can maintain cardiac output. The clinical signature — inferior ST elevation, hypotension, JVD, clear lungs, V4R elevation — should trigger immediate recognition and a shift from vasodilators to volume resuscitation. This pattern recognition, practiced before the call, is what separates a provider who manages the presentation from one who inadvertently worsens it.
Chester Shermer, MD, FACEP is the Founder and Medical Director of Global MedOps Command. All clinical content on EMS-MedSim is developed and reviewed by Dr. Shermer and grounded in current AHA, NAEMSP, and NREMT guidelines.
Practice this scenario: Launch the Nitroglycerin in RVI simulation →
Frequently Asked Questions
Why is nitroglycerin dangerous in right ventricular infarction?
An infarcted right ventricle is preload-dependent, and nitroglycerin's venodilation cuts that preload — the drop in cardiac output can produce profound hypotension.
How do you recognize RV involvement in the field?
Inferior STEMI plus the clinical triad — hypotension, clear lungs, elevated jugular venous pressure — confirmed where possible with right-sided leads (ST elevation in V4R).
What is the correct treatment?
Hold nitrates and other preload reducers, support pressure with fluids per protocol, and prioritize rapid transport for reperfusion.